methylprednisolone has been researched along with Sleep Wake Disorders in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 8 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ceanga, M; Chung, HY; Geis, C; Sell, J; Voss, A; Wickel, J; Witte, OW | 1 |
| Chen, WX; Li, JL; Liang, HC; Liang, W; Peng, BW; Yang, SY; Zhang, FQ | 1 |
| Boss, HM; Braun, KP; de Jager, W; de Vries, EE; Jansen, FE; van den Munckhof, B; van Royen-Kerkhof, A; Willemsen, MA | 1 |
| Csábi, G; Hau, L; Tényi, T | 1 |
| Dresler, M; Genzel, L; Kluge, M; Rosenhagen, M; Schüssler, P; Steiger, A; Weber, F | 1 |
| Abdelaziz, K; Christie, J; MacDougall, NJ; O'Brien, P; Roberts, R; Swingler, R | 1 |
| Machado, S | 1 |
| Torrelo, A | 1 |
| Antonijevic, IA; Steiger, A | 1 |
| Bataillard, M; Clerc, C; Montiel, P; Richard, P; Sellal, F | 1 |
1 review(s) available for methylprednisolone and Sleep Wake Disorders
| Article | Year |
|---|---|
[Anti-N-methyl-D aspartate receptor encephalitis - guideline to the challenges of diagnosis and therapy].
Topics: Aggression; Animals; Anti-Inflammatory Agents; Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Autoantibodies; Autoimmunity; Cyclophosphamide; Diagnosis, Differential; Female; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Male; Methylprednisolone; Nervous System Diseases; Neuroprotective Agents; Plasmapheresis; Problem Behavior; Prognosis; Receptors, N-Methyl-D-Aspartate; Rituximab; Sex Distribution; Sleep Wake Disorders | 2015 |
2 trial(s) available for methylprednisolone and Sleep Wake Disorders
| Article | Year |
|---|---|
Off-line memory consolidation impairments in multiple sclerosis patients receiving high-dose corticosteroid treatment mirror consolidation impairments in depression.
Topics: Adrenal Cortex Hormones; Adult; Aged; Depression; Dose-Response Relationship, Drug; Female; Humans; Male; Memory; Memory Disorders; Methylprednisolone; Middle Aged; Mitoxantrone; Multiple Sclerosis; Neuroprotective Agents; Psychomotor Performance; Sleep; Sleep Wake Disorders | 2010 |
Depression-like changes of the sleep-EEG during high dose corticosteroid treatment in patients with multiple sclerosis.
Topics: Adult; Depression; Electroencephalography; Encephalomyelitis; Female; Humans; Methylprednisolone; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Polysomnography; Sleep Wake Disorders; Sleep, REM; Time Factors | 2003 |
7 other study(ies) available for methylprednisolone and Sleep Wake Disorders
| Article | Year |
|---|---|
Autoimmune encephalitis with anti-IgLON5 and anti-GABAB-receptor antibodies: A case report.
Topics: Administration, Intravenous; Autoantibodies; Cell Adhesion Molecules, Neuronal; Cognitive Dysfunction; Cyclophosphamide; Depressive Disorder; Dysarthria; Encephalitis; GABA-B Receptor Antagonists; Gait Disorders, Neurologic; Glucocorticoids; Hallucinations; Hashimoto Disease; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Plasmapheresis; Sleep Wake Disorders; Treatment Outcome | 2019 |
Acquired epileptiform opercular syndrome evaluated with real-time transcranial Doppler ultrasound-video-electroencephalogram before and after treatment: a case report.
Topics: Anticonvulsants; Child, Preschool; Electroencephalography; Humans; Male; Methylprednisolone; Seizures; Sleep; Sleep Wake Disorders; Status Epilepticus; Syndrome; Treatment Failure; Ultrasonography, Doppler, Transcranial; Valproic Acid | 2019 |
Serum inflammatory mediators correlate with disease activity in electrical status epilepticus in sleep (ESES) syndrome.
Topics: Adolescent; Case-Control Studies; Chemokine CCL2; Chemokine CCL3; Child; Child, Preschool; Cognition Disorders; Cytokines; Electroencephalography; Female; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Inflammation; Interleukin-10; Interleukin-1alpha; Interleukin-6; Interleukin-8; Intramolecular Oxidoreductases; Language Disorders; Macrophage Migration-Inhibitory Factors; Male; Methylprednisolone; Neuropsychological Tests; Prednisolone; Sleep Wake Disorders; Status Epilepticus; Syndrome; Treatment Outcome | 2016 |
Not hysteria: ovarian teratoma-associated anti-N-methyl-D-aspartate receptor encephalitis.
Topics: Adult; Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Autoantibodies; Cognition Disorders; Dermoid Cyst; Dyskinesias; Female; Humans; Laparoscopy; Methylprednisolone; Ovarian Neoplasms; Ovariectomy; Personality Disorders; Prednisolone; Receptors, N-Methyl-D-Aspartate; Sleep Wake Disorders; Treatment Outcome | 2012 |
Effective use of methylprednisolone aceponate 0.1% in a 9-month-old infant with atopic eczema and sleep disturbance.
Topics: Administration, Topical; Anti-Inflammatory Agents; Dermatitis, Atopic; Humans; Infant; Male; Methylprednisolone; Sleep Wake Disorders | 2012 |
Successful treatment of widespread eczema and sleep disruption in a 7-month-old infant with methylprednisolone aceponate 0.1%.
Topics: Administration, Topical; Anti-Inflammatory Agents; Eczema; Filaggrin Proteins; Humans; Infant; Male; Methylprednisolone; Sleep Wake Disorders | 2012 |
[Limbic encephalitis with severe sleep disorder associated with voltage-gated potassium channels (VGKCs) antibodies].
Topics: Autoantibodies; Confusion; Female; Humans; Immunoglobulins; Limbic Encephalitis; Methylprednisolone; Middle Aged; Polysomnography; Potassium Channels, Voltage-Gated; Seizures; Sleep Wake Disorders; Treatment Outcome | 2008 |